Pyruvate Kinase Deficiency Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Pyruvate Kinase Deficiency stocks.

Pyruvate Kinase Deficiency Stocks Recent News

Date Stock Title
May 8 AGIO Wall Street Analysts See a 26.01% Upside in Agios Pharmaceuticals (AGIO): Can the Stock Really Move This High?
May 7 RCKT Rocket's (RCKT) Q1 Loss Narrower Than Expected, Sales Nil
May 6 RCKT Rocket Pharmaceuticals GAAP EPS of -$0.66 beats by $0.01
May 6 RCKT Rocket Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Progress
May 6 AGIO Agios to Present at the BofA Securities 2024 Health Care ConferenceĀ on May 16, 2024
May 5 AGIO Earnings Beat: Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
May 3 AGIO Agios (AGIO) Q1 Earnings Surpass, Sales Miss Estimates
May 3 AGIO Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q1 2024 Earnings Call Transcript
May 3 AGIO Agios to Present at the RBC Capital Markets Global Healthcare ConferenceĀ on May 14, 2024
May 3 AGIO Agios Pharmaceuticals First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
May 3 AGIO Agios Pharmaceuticals Inc (AGIO) (Q1 2024) Earnings Call Transcript Highlights: Strategic ...
May 3 AGIO Q1 2024 Agios Pharmaceuticals Inc Earnings Call
May 2 AGIO Agios Pharmaceuticals, Inc. 2024 Q1 - Results - Earnings Call Presentation
May 2 AGIO Agios Pharmaceuticals, Inc. (AGIO) Q1 2024 Earnings Call Transcript
May 2 AGIO Agios Pharmaceuticals Reports Q1 2024 Earnings: Narrower Loss than Expected with Strong Revenue ...
May 2 AGIO Agios Pharmaceuticals (AGIO) Reports Q1 Loss, Misses Revenue Estimates
May 2 AGIO Agios Pharmaceuticals GAAP EPS of -$1.45 beats by $0.20, revenue of $8.19M misses by $0.18M
May 2 AGIO Agios Reports Business Highlights and First Quarter 2024 Financial Results
Pyruvate Kinase Deficiency

Pyruvate kinase deficiency is an inherited metabolic disorder of the enzyme pyruvate kinase which affects the survival of red blood cells. Both autosomal dominant and recessive inheritance have been observed with the disorder; classically, and more commonly, the inheritance is autosomal recessive. Pyruvate kinase deficiency is the second most common cause of enzyme-deficient hemolytic anemia, following G6PD deficiency.

Browse All Tags